All In MedTech

Device Trial Radar · NCT02266810

Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implant in Frontal Sinus

The PROGRESS Study: Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implants Following Surgical Opening of the Frontal Sinus for Chronic Sinusitis: A Randomized Blinded Controlled Study

Last checked: Nov 20, 2026Latest source record: Aug 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

160

Actual

Start

Sep 2014

Primary completion

Apr 2016

Study completion Oct 2016

Sponsor

Lead sponsor
Intersect ENTNot on our public-company list
Sponsor type
Industry
Collaborators
Advance Research Associates
First posted
Oct 17, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the PROGRESS Study is to assess the safety and efficacy of the Propel Mini and Propel Nova steroid-eluting Sinus Implants when placed in the frontal sinus opening following frontal sinus surgery in patients with chronic sinusitis.

Conditions

  • Chronic Sinusitis

Interventions

  • PROPEL Mini Sinus Implant.Device

    Placement of sinus implant following frontal sinus surgery

  • Sinus Surgery aloneProcedure

    Sinus surgery only, without implant placement

  • Propel Nova Sinus ImplantDevice

    Placement of sinus implant following frontal sinus surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of Sinuses That Require Post-operative Interventions (Propel Mini Cohort)Time frame: Day 30
  2. Percent of Sinuses That Require Post-operative Interventions (Propel Nova Cohort)Time frame: Day 30

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Sacramento Ear, Nose and Throat

    Sacramento, California

  • Breathe Clear Institute of Sinus and Allergy Relief

    Torrance, California

  • The Connecticut Center for Advanced ENT Care

    Norwalk, Connecticut

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.